tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steven Lichtman, 107 are a BUY (88.43%), 14 are a HOLD (11.57%).
Analyst Steven Lichtman works at OPPENHEIMER with a stock forecast success ratio of 61.77% fulfilled within 162.68 days on average.
Steven Lichtman’s has documented 266 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ZBH, Zimmer Biomet Holdings at 03-May-2024.
Analyst best performing recommendations are on BWAY (BRAINSWAY LTD).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 2/27/2019. The price target of $68 was fulfilled within 2 days with a profit of $6.14 (9.93%) receiving and performance score of 49.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
78
$5.15 (7.07%)
60
10 days ago
14/15 (93.33%)
$4.83 (6.60%)
513
Hold
73
$0.15 (0.21%)
55
11 days ago
4/4 (100%)
$-0.26 (-0.35%)
77
Buy
85
$12.15 (16.68%)
80
11 days ago
3/5 (60%)
$11.74 (16.03%)
110
Buy
82
$9.15 (12.56%)
72
11 days ago
3/4 (75%)
$8.74 (11.93%)
560
Buy
85
$12.15 (16.68%)
73
11 days ago
17/18 (94.44%)
$11.74 (16.03%)
346
Which stock is Steven Lichtman is most bullish on?
Which stock is Steven Lichtman is most reserved on?
What Year was the first public recommendation made by Steven Lichtman?
